Sodium-glucose co-transporter-2 inhibitors use in patients with reduced kidney function hospitalized for fluid overload and heart failure: an observational study.
在因液體過載和心臟衰竭住院的腎功能減退患者中使用鈉-葡萄糖共轉運蛋白-2抑制劑:一項觀察性研究。
Cardiorenal Med 2024-07-21
Impact of Inpatient Initiation of Sodium-Glucose Cotransporter-2 Inhibitors on Prescription Rates in Patients With Heart Failure With Reduced Ejection Fraction.
住院患者開始使用鈉葡萄糖共轉運子-2抑制劑對心衰患者降低射血分數處方率的影響。
Am J Cardiol 2023-10-12
Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry.
美國心衰患者住院治療中鈉葡萄糖共同轉運蛋白-2抑製劑治療的當代應用:《遵循指南-心衰病例登記》研究。
JAMA Cardiol 2024-03-07
Utilization rates and predictors of sodium glucose cotransporter 2 inhibitor use in patients with heart failure with or without type 2 diabetes.
心衰患者中是否合併2型糖尿病,對於鈉葡萄糖共同轉運蛋白2抑制劑的使用率及預測因子。
Am J Health Syst Pharm 2023-12-17
Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by AKI.
急性心衰併發腎損傷的急性心衰住院患者使用鈉葡萄糖共轉運輸蛋白-2抑製劑的相關結果。
Kidney360 2024-03-12
Evaluation of Inpatient Sodium-Glucose Co-Transporter-2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure.
住院急性心衰患者中鈉葡萄糖共同轉運蛋白-2抑製劑使用的評估。
Am J Cardiol 2024-01-08
Prescribing patterns of SGLT-2 inhibitors for patients with heart failure: A two-center analysis.
心衰患者 SGLT-2 抑制劑的處方模式:兩家醫療中心的分析。
Am Heart J Plus 2024-03-22
Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge.
心力衰竭患者出院時鈉葡萄糖轉運蛋白2 (SGLT2) 抑製劑處方模式評估。
J Pharm Pract 2024-05-28